NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny due to a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][2][5]. Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a lawsuit claiming SelectQuote misled investors about its business model and regulatory risks, particularly regarding its Medicare Advantage sales practices [1][4][6]. - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that the company failed to disclose material risks associated with its sales practices [2][6]. Allegations of Misconduct - The complaint alleges that SelectQuote misrepresented its services as providing unbiased advice while actually directing customers towards higher-commission plans and accepting illegal kickbacks [4][8]. - The DOJ's allegations indicate that SelectQuote received tens of millions of dollars in improper payments from 2016 to 2021, which contributed to discriminatory practices against less profitable customers [4][8]. Market Reaction - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% in a single day, and shares have declined over 40% in the past six months due to investor concerns about legal exposure and reputational damage [5][6]. Investigative Actions - Hagens Berman, a shareholder rights firm, is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, emphasizing the seriousness of the DOJ's intervention [7]. - The firm is encouraging investors who suffered losses or have relevant information to come forward, highlighting the potential for whistleblower rewards under the SEC program [7][9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 10, 2025 [4][6]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage plans and received illegal kickbacks from insurers [6]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021, leading to a significant drop in stock price [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, are encouraged to discuss their legal rights and options [1][4]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the deadline for applications set for October 10, 2025 [8]. - Faruqi & Faruqi is also seeking information from whistleblowers and former employees regarding SelectQuote's conduct [9].

Group 1 - The core point of the news is that SelectQuote, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from September 9, 2020, to May 1, 2025, with a deadline for lead plaintiff applications set for October 10, 2025 [1][3] - The U.S. Department of Justice filed a complaint against SelectQuote on May 1, 2025, alleging that the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021, which led to a significant drop in the company's stock price by 19.2% to $2.56 per share on the same day [4] - ClaimsFiler is a service that assists retail investors in recovering funds from securities class action settlements, providing resources for investors to register, upload transactional data, and seek legal evaluations [5][6] Group 2 - The lawsuit against SelectQuote includes allegations of conspiracy with major insurers to discriminate against less profitable Medicare beneficiaries and making materially false claims regarding unbiased coverage comparisons [4] - Investors affected by the lawsuit are encouraged to visit ClaimsFiler's website or contact the law firm Kahn Swick & Foti, LLC for legal assistance [2]

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [6]. Allegation Details - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [6]. - The lawsuit claims that SelectQuote made materially false statements and failed to disclose adverse facts about its operations, including directing beneficiaries to plans that compensated the company the most, rather than providing unbiased comparisons [6]. Stock Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6]. Legal Process - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, have until October 10, 2025, to apply to be appointed as lead plaintiff in the lawsuit [6].

Core Viewpoint - SelectQuote Inc. is under legal scrutiny due to allegations of deceptive sales practices related to its Medicare Advantage plans, leading to a significant drop in its stock price and a class-action lawsuit from investors [1][4][5]. Legal Allegations - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., claims that SelectQuote misled investors about its business model and regulatory risks from September 9, 2020, to May 1, 2025 [2][5]. - Allegations include that SelectQuote misrepresented its sales practices, promoting "unbiased advice" while actually steering customers towards higher-commission plans and accepting illegal kickbacks [3][7]. Market Impact - Following the DOJ's intervention, SelectQuote's stock price fell nearly 20% on May 1, 2025, and has since declined over 40% in the past six months, reflecting investor concerns about legal exposure and reputational damage [4][5]. Investigative Actions - Hagens Berman is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, indicating that the DOJ's involvement elevates the situation to a serious federal matter [6][8].

Accessibility StatementSkip Navigation NEW YORK, Oct. 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the "Class Period"), of the important October 10, 2025 lead plaintiff deadline. So what: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thr ...

LOS ANGELES, Oct. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SLQT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as le ...

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Accessibility StatementSkip Navigation LOS ANGELES, Oct. 1, 2025 /PRNewswire/ --Â The Law Offices of Frank R. Cruz announces that investors with losses related to SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:Â SLQT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SELECTQUOTE, INC. (SLQT), CLICK HEREÂ BEFORE OCTOBER 10, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Â What Is The Lawsuit ...